Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann–Pick C1
- 1 March 2012
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 101 (1) , 125-131
Abstract
No abstract availableKeywords
Funding Information
- NIH (5RO1 ED000343-5, AG-U01028583, 2R01DK067286)
- Addi and Cassi Fund
This publication has 54 references indexed in Scilit:
- SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcuminAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expressionLipids in Health and Disease, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protectionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanismMolecular Cancer Therapeutics, 2008
- Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s DiseaseThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcuminProceedings of the National Academy of Sciences, 2007
- CURCUMIN: THE INDIAN SOLID GOLD2007
- Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann–Pick C diseaseProceedings of the National Academy of Sciences, 2006
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005